Jerry Shen

AceLink Therapeutics, Inc. is a biopharmaceutical startup founded in 2018 that focuses on developing safe and effective medicines to address genetic diseases with high unmet needs. AceLink Therapeutics is based in Newark, CA. The private company's initial focus is on developing novel therapeutics for Fabry disease and type 1 Gaucher disease. The company was founded in 2018 by Wen Chen, Marvin R. Garovoy, and Jerry Shen. Jerry Shen has been the CEO since 2018.

Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX.

Applied Biomics, Inc. is a proteomics service company that specializes in 2D DIGE in-gel data analysis, which is ideal for comparing up to three samples in a single 2D DIGE gel. The private company was founded by Jerry Shen in 2005 and is based in Hayward, CA. Applied Biomics provides top-quality, cost-effective, and full-line proteomics services, from sample preparation to publication-ready data. In addition to their main services, they also offer a wide range of other proteomics services to supplement research needs for academic labs, government institutes, or commercial enterprises. Customized proteomics projects are also available.

Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.

LEAD Therapeutics, Inc. develops therapeutic drugs. The company was founded Charles Hsu, Leonard E. Post, Peter L. Myers and Sofie Qiao in May 2006 and is headquartered in San Bruno, CA.